To Evaluate Efficacy and Safety of Sofosbuvir in Combination with Daclatasvir or Simeprevir for 12 Weeks in Patients with Advanced Liver Disease Receiving
Latest Information Update: 14 Aug 2015
At a glance
- Drugs Daclatasvir (Primary) ; Simeprevir (Primary) ; Sofosbuvir (Primary)
- Indications Liver disorders
- Focus Therapeutic Use
Most Recent Events
- 14 Aug 2015 New trial record